Log In
Print
BCIQ
Print
Print this Print this
 

CCX507

  Manage Alerts
Collapse Summary General Information
Company ChemoCentryx Inc.
DescriptionSmall molecule third-generation CC chemokine receptor 9 (CCR9; CDw199) inhibitor
Molecular Target CC chemokine receptor 9 (CCR9) (CDw199)
Mechanism of ActionCC chemokine receptor 9 (CCR9) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel disease (IBD); Treat ulcerative colitis (UC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today